Proportion of high-risk patients | *θ* | 0.5,[0,1] | [39] |

Proportions of colonized patients in the high-risk and low-risk groups at admission | *λ*_{CH},*λ*_{CL} | 0.2, 0.05 | [40] |

Proportions of infected patients in the high-risk and low-risk groups at admission | *λ*_{IH},*λ*_{IL} | 0.01, 0 | [41] |

Discharge rates of uncolonized and colonized patients in the | *γ*_{H},*γ*_{L} high-risk and low-risk groups | 1/9,1/5 | [29, 42, 43] |

Probabilities of developing an MRSA infection in high-risk and low-risk patients | *p*_{H},*p*_{L} | 0.2, 0.05 | [41, 44] |

Treatment rates for high-risk and low-risk patients | *ν*_{H},*ν*_{L} | 1/10,1/5 | [45] |

Probabilities of MRSA-related death in high-risk and low-risk patients | *d*_{H},*d*_{L} | 0.3, 0.15 | [14, 39, 46] |

Total numbers of patients | *N*_{p} | 48 | |

Ratio of patients to HCWs | *r* | 4 | [39] |

Decontamination rate in HCWs | *η* | 24 | [13] |

Per capita contact rate | *c* | 1.38 | [30] |

Probability of successful colonization | *q* | 0.01 | [13, 31] |

Probability of successful contamination for colonized and infected patients | *q*_{C},*q*_{I} | 0.17, 0.25 | [13, 32] |

Transmission coefficient from contaminated HCWs to uncolonized patients | *β* | *c**q**N*_{p} | |

Transmission coefficients from colonized and infected patients to uncontaminated HCWs | *α*_{C},*α*_{I} | *c**q*_{C}*N*_{p},*c**q*_{I}*N*_{p} | |

Control factor for targeted measures on high-risk patients | *σ* | 0.5,[0,1] | varying |

Control factor for targeted measures on infected patients | *κ* | 0.5,[0,1] | varying |